Cannabis Science Distributors Sells Out of Initial Test Batch of Inhalers

Cannabis Science, Inc. (otc pink:CBIS), a U.S. company specializing in the development of cannabis-based medicines, announces its California distributors have sold out of Cannabis Science's recently released CBIS Metered Dose Inhalers (MDI) in an initial test market run in the State of California. Cannabis Science is excited to report it has increased production of the inhalers to meet this new consumer demand.

Cannabis Science's CEO, Mr. Raymond C. Dabney, stated, "We did not expect demand for our Inhaler to increase so rapidly. While it was not a particularly large initial test batch, there were certainly enough indicators in the pilot program that point to a great success considering the application and target market. Consequently, we have substantially increased production with our current manufacturer and are identifying and implementing key manufacturing and distribution expansions to ensure we meet the growing demand for the CBIS MDI Inhaler."

As previously noted, the California...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.